General Summary

Dr. Ross specializes in urology and urologic oncology and is a nationally recognized expert in prostate cancer. Dr. Ross performs prostate cancer screening, prostate biopsy (including MRI-fusion biopsy), active surveillance, robotic prostatectomy, open radical prostatectomy, and salvage and primary cryoablation of the prostate. Prior to joining Texas Urology Specialists, Dr. Ross served as director of the Johns Hopkins Urology Prostate Cancer Program and as an associate professor in the Johns Hopkins School of Medicine departments of urology and oncology.


  • Residency in Urology
    Chief Resident, Johns Hopkins Medical Institution, Baltimore, MD
  • Internship in Surgery
    Johns Hopkins Medical Institution, Baltimore, MD
  • Medical Doctorate
    Johns Hopkins University School of Medicine, Baltimore, MD
  • Doctor of Biochemistry, Cellular and Molecular Biology
    Johns Hopkins University School of Medicine, Baltimore, MD

Surgery Locations

  • Baylor Scott & White Medical Center – Frisco
  • Baylor Scott & White Medical Center – Plano
  • Medical City Dallas Hospital, Dallas



Accolades & Memberships

  • Alpha Omega Alpha
  • American Urologic Association
  • American Society of Clinical Oncology
  • Prostate Cancer Foundation Young Investigator Award, 2015
  • Department of Defense Prostate Cancer Research Award, 2015
  • Patrick C. Walsh Research Award, 2015
  • Johns Hopkins Clinical Scientist Award, 2012

Scholarly Leadership

Dr. Ross has published more than 90 peer reviewed articles related to prostate cancer. He currently is an associate editor of the journals Prostate Cancer and Prostatic Diseases, Urology, and the Annals of Surgical Oncology, and serves on the editorial board of the British Journal of Urology, and Urology Practice. He has been invited to moderate and speak at meetings of the American Urological Association, American Society of Radiation Oncologists, Society of Urological Oncology, National Comprehensive Cancer Network, and Prostate Cancer Foundation.

Other Information

Dr. Ross enjoys hiking, spending time with family and motorcycle riding.


Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model
Journal of Clinical Oncology, 2017

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens
European Urology, 2017

Genomic Testing for Localized Prostate Cancer: Where Do We Go from Here?
Current Opinions in Urology, 2017

Use of the Prostate Health Index for Detection of Prostate Cancer: Results from a Large Academic Practice
Prostate Cancer Prostatic Diseases, 2017

Dynamic Contrast Enhanced MRI Improves Classification of Prostate Lesions: A Study of Pathologic Outcomes on Targeted Prostate Biopsy
Journal of Urology, 2017

Show all Publications

PSMA-targeted 18F-DCFPyL PET/CT in the Preoperative Staging of Men with High-risk Prostate Cancer: Results of a Prospective Phase II Single-Center Study
Journal of Urology, 2017

Efficacy of Post-Operative Radiation in a Prostatectomy Cohort Adjusted for Clinical and Genomic Risk
Prostate Cancer Prostatic Diseases, 2016

Molecular Analysis of Low Grade Prostate Cancer Utilizing a Genomic Classifier of Metastatic Potential
Journal of Urology, 2016

Development and Validation of a 24-Gene Predictor of Response to Postoperative Radiotherapy in Prostate Cancer: A Matched Retrospective Analysis
Lancet Oncology, 2016

Multigene Testing in Localized Prostate Cancer
Journal of the National Comprehensive Cancer Network, 2016

Oligometastatic Prostate Cancer: Definitions, Clinical Outcomes and Treatment Considerations
Nature Reviews Urology, 2016